UH3HL151310
Cooperative Agreement
Overview
Grant Description
Actions to Decrease Disparities in Risk and Engage in Shared Support for Blood Pressure Control (ADDRESS-BP) in Blacks - Project Summary/Abstract:
Hypertension (HTN) control in Blacks is sub-optimal due to barriers at the patient, health systems, provider, and community-levels of care. Although the efficacy of nurse case management (NCM) and home blood pressure monitoring (HBPM) is well-proven; these strategies do not address community-level barriers (unstable housing, transportation) to adequate HTN control, thus limiting their impact in Blacks.
Integration of community health worker (CHWs) into primary care to help patients navigate community resources is effective for HTN control in patients experiencing community-level barriers. Despite their efficacy, implementation of these multi-level evidence-based interventions (NCM, HBPM, and use of CHWs) into routine care in real world primary care practices, where a majority of minority patients receive care, is suboptimal.
This proposal harnesses practice facilitation (PF)- a theoretically sound and sustainable implementation strategy to evaluate the implementation of NCM, HBPM, and CHWs delivered as an integrated community-clinic linkage model [Practice Support and Community Engagement (PACE)] to address patient-, physician-, health system-, and community-level barriers to HTN control in Blacks.
We will test the implementation of PACE across a network of 20 primary practices within NYU Langone Health in NYC, in partnership with an established community-clinic-academic advisory board and Healthfirst (NYC's largest Medicaid payer).
Practice facilitators will assist practices to integrate NCM and HBPM into the clinic workflow for 6 months, after which the patients' BP control status are re-evaluated; and for those who remain uncontrolled, the facilitators will assist practices to develop processes for the addition of a CHW to the care team to help patients navigate community resources and address community-level barriers to optimal HTN control.
NCM comprises home BP telemonitoring, behavioral counseling, and medication adjustment/titration by trained nurses. Trained CHWs work in partnership with nurses to enhance care coordination, and provide health coaching and bi-directional referrals between the practices and community resources.
We will conduct the proposed study in two phases: 1) a UG3 phase that will use principles of community-based participatory research and the Consolidated Framework of Implementation Research to develop a context-specific PF strategy and; 2) a UH3 implementation phase that will use Proctor's Implementation Outcomes Framework to evaluate, in a stepped-wedge cluster RCT of 20 primary care practices in 500 Black patients with uncontrolled HTN, the effect of the PF strategy on clinical and cost-effectiveness of PACE.
We will also examine adoption and implementation fidelity as potential mechanisms that may explain the impact of PF on BP control. Primary outcome is BP control from baseline to 18 months. Secondary outcome is cost-effectiveness of PACE.
The study's findings will provide a practical and sustainable system that harnesses existing clinical and community resources to build capacity for primary care practices to manage HTN control in minority populations.
Hypertension (HTN) control in Blacks is sub-optimal due to barriers at the patient, health systems, provider, and community-levels of care. Although the efficacy of nurse case management (NCM) and home blood pressure monitoring (HBPM) is well-proven; these strategies do not address community-level barriers (unstable housing, transportation) to adequate HTN control, thus limiting their impact in Blacks.
Integration of community health worker (CHWs) into primary care to help patients navigate community resources is effective for HTN control in patients experiencing community-level barriers. Despite their efficacy, implementation of these multi-level evidence-based interventions (NCM, HBPM, and use of CHWs) into routine care in real world primary care practices, where a majority of minority patients receive care, is suboptimal.
This proposal harnesses practice facilitation (PF)- a theoretically sound and sustainable implementation strategy to evaluate the implementation of NCM, HBPM, and CHWs delivered as an integrated community-clinic linkage model [Practice Support and Community Engagement (PACE)] to address patient-, physician-, health system-, and community-level barriers to HTN control in Blacks.
We will test the implementation of PACE across a network of 20 primary practices within NYU Langone Health in NYC, in partnership with an established community-clinic-academic advisory board and Healthfirst (NYC's largest Medicaid payer).
Practice facilitators will assist practices to integrate NCM and HBPM into the clinic workflow for 6 months, after which the patients' BP control status are re-evaluated; and for those who remain uncontrolled, the facilitators will assist practices to develop processes for the addition of a CHW to the care team to help patients navigate community resources and address community-level barriers to optimal HTN control.
NCM comprises home BP telemonitoring, behavioral counseling, and medication adjustment/titration by trained nurses. Trained CHWs work in partnership with nurses to enhance care coordination, and provide health coaching and bi-directional referrals between the practices and community resources.
We will conduct the proposed study in two phases: 1) a UG3 phase that will use principles of community-based participatory research and the Consolidated Framework of Implementation Research to develop a context-specific PF strategy and; 2) a UH3 implementation phase that will use Proctor's Implementation Outcomes Framework to evaluate, in a stepped-wedge cluster RCT of 20 primary care practices in 500 Black patients with uncontrolled HTN, the effect of the PF strategy on clinical and cost-effectiveness of PACE.
We will also examine adoption and implementation fidelity as potential mechanisms that may explain the impact of PF on BP control. Primary outcome is BP control from baseline to 18 months. Secondary outcome is cost-effectiveness of PACE.
The study's findings will provide a practical and sustainable system that harnesses existing clinical and community resources to build capacity for primary care practices to manage HTN control in minority populations.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New York,
New York
100165267
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 342% from $1,345,315 to $5,950,158.
New York University was awarded
PACE: Addressing HTN Disparities in Blacks
Cooperative Agreement UH3HL151310
worth $5,950,158
from National Heart Lung and Blood Institute in September 2020 with work to be completed primarily in New York New York United States.
The grant
has a duration of 7 years and
was awarded through assistance program 93.837 Cardiovascular Diseases Research.
The Cooperative Agreement was awarded through grant opportunity Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 9/21/26
Period of Performance
9/10/20
Start Date
8/31/27
End Date
Funding Split
$6.0M
Federal Obligation
$0.0
Non-Federal Obligation
$6.0M
Total Obligated
Activity Timeline
Transaction History
Modifications to UH3HL151310
Additional Detail
Award ID FAIN
UH3HL151310
SAI Number
UH3HL151310-2037107677
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Funding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Awardee UEI
M5SZJ6VHUHN8
Awardee CAGE
3D476
Performance District
NY-12
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Heart, Lung, and Blood Institute, National Institutes of Health, Health and Human Services (075-0872) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,345,315 | 100% |
Modified: 9/21/26